Andrés Alloatti

Andrés Alloatti

Auto-generated profile, based on publicly available information

Andrés Alloatti

PSL Research University, Institut Curie Research Center, INSERM U932, 75005 Paris, France

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 June 2016 in Immunological Reviews
Verified
Journal Article
Open access
PDF file
AAAndrés Alloatti
Andrés Alloatti
FKFiorella Kotsias
Fiorella Kotsias
JMJoao Gamelas Magalhaes
Joao Gamelas Magalhaes
SASebastian Amigorena
Sebastian Amigorena
Summary: As a population, dendritic cells (DCs) appear to be the best cross‐presenters of internalized antigens on major histocompatibility complex class I molecules in the mouse. To do this, DCs have developed a number of unique and dedicated means to control their endocytic and phagocytic pathways: among them, the capacity to limit acidification of their phagosomes, to prevent proteolytic degradation, to delay fusion of phagosomes to lysosomes, to recruit ER proteins to phagosomes, and to export phagocytosed antigens to the cytosol. The regulation of phagocytic functions, and thereby of antigen processing and presentation by innate signaling, represents a critical level of integration of adaptive and innate immune responses. Understanding how innate signals control antigen cross‐presentation is critical to define effective vaccination strategies for CD8+ T‐cell responses.

1 December 2015 in Immunity
Verified
Journal Article
Closed access
AAAndrés Alloatti
Andrés Alloatti
FKFiorella Kotsias
Fiorella Kotsias
APAnne-Marie Pauwels
Anne-Marie Pauwels
JCJean-Marie Carpier
Jean-Marie Carpier
MJMabel Jouve
Mabel Jouve
SASebastian Amigorena
Sebastian Amigorena

29 June 2017 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
AAAndrés Alloatti
Andrés Alloatti
DRDerek C. Rookhuizen
Derek C. Rookhuizen
LJLeonel Joannas
Leonel Joannas
JCJean-Marie Carpier
Jean-Marie Carpier
Salvador IborraSalvador Iborra
Salvador Iborra
SASebastian Amigorena
Sebastian Amigorena
CD8+ T cells mediate antigen-specific immune responses that can induce rejection of solid tumors. In this process, dendritic cells (DCs) are thought to take up tumor antigens, which are processed into peptides and loaded onto MHC-I molecules, a process called “cross-presentation.” Neither the actual contribution of cross-presentation to antitumor immune responses nor the intracellular pathways involved in vivo are clearly established because of the lack of experimental tools to manipulate this process. To develop such tools, we generated mice bearing a conditional DC-specific mutation in the sec22b gene, a critical regulator of endoplasmic reticulum–phagosome traffic required for cross-presentation. DCs from these mice show impaired cross-presentation ex vivo and defective cross-priming of CD8+ T cell responses in vivo. These mice are also defective for antitumor immune responses and are resistant to treatment with anti–PD-1. We conclude that Sec22b-dependent cross-presentation in DCs is required to initiate CD8+ T cell responses to dead cells and to induce effective antitumor immune responses during anti–PD-1 treatment in mice.

1 February 2011 in Molecular and Biochemical Parasitology
Verified
Journal Article
Closed access
AAAndrés Alloatti
Andrés Alloatti
AUAntonio D. Uttaro
Antonio D. Uttaro

3 January 2023 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
ABAmélie Bonaud
Amélie Bonaud
LGLaetitia Gargowitsch
Laetitia Gargowitsch
SGSimon M. Gilbert
Simon M. Gilbert
ERElanchezhian Rajan
Elanchezhian Rajan
PCPablo Canales-Herrerias
Pablo Canales-Herrerias
MEMarion Espéli
Marion Espéli
Despite the essential role of plasma cells in health and disease, the cellular mechanisms controlling their survival and secretory capacity are still poorly understood. Here, we identified the soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) Sec22b as a unique and critical regulator of plasma cell maintenance and function. In the absence of Sec22b, plasma cells were hardly detectable and serum antibody titers were dramatically reduced. Accordingly, Sec22b -deficient mice fail to mount a protective immune response. At the mechanistic level, we demonstrated that Sec22b contributes to efficient antibody secretion and is a central regulator of plasma cell maintenance through the regulation of their transcriptional identity and of the morphology of the endoplasmic reticulum and mitochondria. Altogether, our results unveil an essential and nonredundant role for Sec22b as a regulator of plasma cell fitness and of the humoral immune response.
1

15 July 2009 in International Journal for Parasitology
Verified
Journal Article
Closed access
AAAndrés Alloatti
Andrés Alloatti
STSebastián A. Testero
Sebastián A. Testero
AUAntonio D. Uttaro
Antonio D. Uttaro